Literature DB >> 28091918

Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.

A I Osip'yants1,2, E N Knyazev1,2, A V Galatenko1, K M Nyushko2, V V Galatenko1, M Yu Shkurnikov3, B Ya Alekseev2.   

Abstract

We performed diagnostic classification of plasma specimens from patients with non-metastatic and metastatic prostate cancer based on pairs of miRNA that have no individual diagnostic significance. Of 230 miRNA detected in plasma specimens, 3 pairs were diagnostically significant. The miRNA pair hsa-miR-19b-3p and hsa-miR-297 demonstrated highest sensitivity and specificity. Among common target genes of these miRNA, CFL2 gene associated with cell mobility was detected.

Entities:  

Keywords:  blood plasma; little invasive diagnosis; miRNA; prostate cancer

Mesh:

Substances:

Year:  2017        PMID: 28091918     DOI: 10.1007/s10517-017-3620-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  11 in total

1.  miR19b-3p promotes the growth and metastasis of colorectal cancer via directly targeting ITGB8.

Authors:  Liang Huang; Jin Lin Cai; Pin Zhu Huang; Liang Kang; Mei Jin Huang; Lei Wang; Jian Ping Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

2.  MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.

Authors:  Rocío B Duca; Cintia Massillo; Guillermo N Dalton; Paula L Farré; Karen D Graña; Kevin Gardner; Adriana De Siervi
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

3.  Circular RNA Complement Factor H (CFH) Promotes Glioma Progression by Sponging miR-149 and Regulating AKT1.

Authors:  Aimiao Bian; Yanping Wang; Ji Liu; Xiaodong Wang; Dai Liu; Jian Jiang; Lianshu Ding; Xiaobo Hui
Journal:  Med Sci Monit       Date:  2018-08-16

4.  A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs.

Authors:  Konrad Pagacz; Przemyslaw Kucharski; Urszula Smyczynska; Szymon Grabia; Dipanjan Chowdhury; Wojciech Fendler
Journal:  BMC Genomics       Date:  2020-01-31       Impact factor: 3.969

Review 5.  Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.

Authors:  Hao Wang; Ran Peng; Junjie Wang; Zelian Qin; Lixiang Xue
Journal:  Clin Epigenetics       Date:  2018-04-23       Impact factor: 6.551

6.  Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.

Authors:  Andrea Polo; Silvia Marchese; Giuseppina De Petro; Maurizio Montella; Gennaro Ciliberto; Alfredo Budillon; Susan Costantini
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

7.  Emerging Role of Extracellular Vesicles in Prostate Cancer.

Authors:  Megan Ludwig; Rhea Rajvansh; Justin M Drake
Journal:  Endocrinology       Date:  2021-09-01       Impact factor: 4.736

Review 8.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02

9.  miRNA-19b-3p Stimulates Cardiomyocyte Apoptosis Induced by Myocardial Ischemia Reperfusion via Downregulating PTEN.

Authors:  Ke Li; Xujie Ya; Xiujuan Duan; Yang Li; Xuefeng Lin
Journal:  Dis Markers       Date:  2021-12-16       Impact factor: 3.434

10.  Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms' tumor.

Authors:  Changjing He; Huatao Qin; Haizhou Tang; Di Yang; Yufeng Li; Zhenwen Huang; Donghu Zhang; Changheng Lv
Journal:  Ann Transl Med       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.